On the recordApril 4, 2022
It is clear that sponsor companies that want to address treatments for these diseases face a number of challenges.
Source
congress.govIt is clear that sponsor companies that want to address treatments for these diseases face a number of challenges.
Kaine highlights challenges faced by companies developing treatments for rare diseases.
Share
More from Tim Kaine
The entire committee believes she’s very well-qualified, and so the question was, ‘Will she have the backbone to stand up against any anti-science if she’s pushed?’
If you require them to pay fully up front and then get a rebate sometime down the road, you really jeopardize their operations.
We’ll keep fighting to reverse these harmful policies, end this unnecessary war, and put more money back in Virginians’ pockets.
Everyone deserves the same opportunity to pursue higher education if they choose.